Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
Hidradenitis Suppurativa: Guidelines and Pipelines
Course Overview
Preview what you'll learn in this program
What You'll Learn
A variety of clinical guidelines have recently been developed for the treatment of Hidradenitis Suppurativa. These guidelines appreciate the complexity of disease as well as a number of gaps in our knowledge regarding disease pathogenesis, disease heterogeneity, and predicting response to therapy.
Our knowledge regarding disease mechanisms and pathogenesis has increased dramatically over the past few years both with regards to clinical associations, disease triggers, genetics, and molecular pathophysiology of disease. These publications question our established treatment approaches and identify multiple novel targets for new therapies.
This course reviews both the existing therapeutic guidelines for HS along with emerging HS therapies, and also discusses how these novel therapies and new knowledge (such as genetics, treatment biomarkers, and new treatments) will shape our management of HS over the next 5 years.
Faculty
Editors
Accreditation Information
A variety of clinical guidelines have recently been developed for the treatment of Hidradenitis Suppurativa. These guidelines appreciate the complexity of disease as well as a number of gaps in our knowledge regarding disease pathogenesis, disease heterogeneity, and predicting response to therapy.
Our knowledge regarding disease mechanisms and pathogenesis has increased dramatically over the past few years both with regards to clinical associations, disease triggers, genetics, and molecular pathophysiology of disease. These publications question our established treatment approaches and identify multiple novel targets for new therapies.
This course reviews both the existing therapeutic guidelines for HS along with emerging HS therapies, and also discusses how these novel therapies and new knowledge (such as genetics, treatment biomarkers, and new treatments) will shape our management of HS over the next 5 years.
✨ Ready to Begin Your Journey? ✨
Enroll now to start the course and unlock all learning materials
Hidradenitis Suppurativa: Guidelines and Pipelines Module
Complete the previous section to unlock this lesson
Course Discussion
Join the conversation with fellow learners
Also Recommended
Hidradenitis Suppurativa: Case Based Management
Managing Pain in a Patient with Hidradenitis Suppurativa
Clinical Approach to Hidradenitis Suppurativa and Emerging Therapies
Understanding Aspects of Shared Decision Making in a Patient with Hidradenitis Suppurativa
